Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 077890

Expand all

AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE (AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE)
EQ 2.5MG BASE;10MG
Marketing Status: Prescription

Active Ingredient: AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
Proprietary Name: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 2.5MG BASE;10MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A077890
Product Number: 001
Approval Date: Oct 14, 2010
Applicant Holder Full Name: WATSON LABORATORIES INC
Marketing Status:  Prescription
Patent and Exclusivity Information

AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE (AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE)
EQ 5MG BASE;10MG
Marketing Status: Prescription

Active Ingredient: AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
Proprietary Name: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 5MG BASE;10MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A077890
Product Number: 002
Approval Date: Oct 14, 2010
Applicant Holder Full Name: WATSON LABORATORIES INC
Marketing Status:  Prescription
Patent and Exclusivity Information

AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE (AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE)
EQ 5MG BASE;20MG
Marketing Status: Prescription

Active Ingredient: AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
Proprietary Name: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 5MG BASE;20MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A077890
Product Number: 003
Approval Date: Oct 14, 2010
Applicant Holder Full Name: WATSON LABORATORIES INC
Marketing Status:  Prescription
Patent and Exclusivity Information

AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE (AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE)
EQ 10MG BASE;20MG
Marketing Status: Prescription

Active Ingredient: AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
Proprietary Name: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 10MG BASE;20MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A077890
Product Number: 004
Approval Date: Oct 14, 2010
Applicant Holder Full Name: WATSON LABORATORIES INC
Marketing Status:  Prescription
Patent and Exclusivity Information